- Previous Close
103.48 - Open
104.24 - Bid --
- Ask --
- Day's Range
103.76 - 107.00 - 52 Week Range
76.20 - 128.61 - Volume
79,035 - Avg. Volume
113,338 - Market Cap (intraday)
5.477B - Beta (5Y Monthly) 1.07
- PE Ratio (TTM)
63.11 - EPS (TTM)
1.69 - Earnings Date May 19, 2025 - May 23, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.
www.corvel.com4,870
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CRVL
View MorePerformance Overview: CRVL
Trailing total returns as of 3/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRVL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRVL
View MoreValuation Measures
Market Cap
5.47B
Enterprise Value
5.34B
Trailing P/E
62.82
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.36
Price/Book (mrq)
18.20
Enterprise Value/Revenue
6.13
Enterprise Value/EBITDA
38.50
Financial Highlights
Profitability and Income Statement
Profit Margin
10.12%
Return on Assets (ttm)
13.99%
Return on Equity (ttm)
33.01%
Revenue (ttm)
871.31M
Net Income Avi to Common (ttm)
88.2M
Diluted EPS (ttm)
1.69
Balance Sheet and Cash Flow
Total Cash (mrq)
162.94M
Total Debt/Equity (mrq)
9.82%
Levered Free Cash Flow (ttm)
62.45M